Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.
Saved in:
| Title: | Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma. |
|---|---|
| Authors: | Diamond B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Baughn L; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Poorebrahim M; Department of Oncology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Poos AM; Heidelberg Myeloma Center, Department of Internal Medicine V, Medical Faculty, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center, Heidelberg, Germany., Lee H; Department of Oncology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Kaddoura M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Wiedmeier-Nutor JE; Department of Medicine, Mayo Clinic, Phoenix, AZ., Durante M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Otteson G; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Jevremovic D; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Tang H; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany.; Division of Translational Medical Oncology, National Center for Tumor Diseases Heidelberg, a partnership between German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Consortium, Heidelberg, Germany.; Division of Translational Precision Medicine, Institute of Human Genetics, Heidelberg University, Heidelberg, Germany., Baertsch MA; Heidelberg Myeloma Center, Department of Internal Medicine V, Medical Faculty, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center, Heidelberg, Germany., Papadimitriou M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Ziccheddu B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Jelinek T; Department of Hematooncology, Faculty of Medicine, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic., Lemoine C; Department of eBiology, Large Molecule Research, Sanofi R&D, Vitry-sur-Seine, France., Rak A; Department of Bio Structure and Biophysics, Integrated Drug Discovery, Sanofi R&D, Vitry-sur-Seine, France., Green DJ; Transplantation and Cellular Therapy Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Neri P; Department of Oncology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Bergsagel L; Department of Medicine, Mayo Clinic, Phoenix, AZ., Braggio E; Department of Medicine, Mayo Clinic, Phoenix, AZ., Kumar S; Department of Medicine, Mayo Clinic, Rochester, MN., Raab MS; Heidelberg Myeloma Center, Department of Internal Medicine V, Medical Faculty, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center, Heidelberg, Germany., Fonseca R; Department of Medicine, Mayo Clinic, Phoenix, AZ., Bahlis N; Department of Oncology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Weinhold N; Heidelberg Myeloma Center, Department of Internal Medicine V, Medical Faculty, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center, Heidelberg, Germany., Maura F; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. |
| Source: | Blood [Blood] 2025 Sep 25; Vol. 146 (13), pp. 1575-1585. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40493883 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Diamond+B%22">Diamond B</searchLink>; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Baughn+L%22">Baughn L</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Poorebrahim+M%22">Poorebrahim M</searchLink>; Department of Oncology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Poos+AM%22">Poos AM</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Medical Faculty, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Lee+H%22">Lee H</searchLink>; Department of Oncology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Kaddoura+M%22">Kaddoura M</searchLink>; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Wiedmeier-Nutor+JE%22">Wiedmeier-Nutor JE</searchLink>; Department of Medicine, Mayo Clinic, Phoenix, AZ.<br /><searchLink fieldCode="AU" term="%22Durante+M%22">Durante M</searchLink>; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Otteson+G%22">Otteson G</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Jevremovic+D%22">Jevremovic D</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Tang+H%22">Tang H</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Fröhling+S%22">Fröhling S</searchLink>; Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany.; Division of Translational Medical Oncology, National Center for Tumor Diseases Heidelberg, a partnership between German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Consortium, Heidelberg, Germany.; Division of Translational Precision Medicine, Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Baertsch+MA%22">Baertsch MA</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Medical Faculty, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Papadimitriou+M%22">Papadimitriou M</searchLink>; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Ziccheddu+B%22">Ziccheddu B</searchLink>; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Jelinek+T%22">Jelinek T</searchLink>; Department of Hematooncology, Faculty of Medicine, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Lemoine+C%22">Lemoine C</searchLink>; Department of eBiology, Large Molecule Research, Sanofi R&D, Vitry-sur-Seine, France.<br /><searchLink fieldCode="AU" term="%22Rak+A%22">Rak A</searchLink>; Department of Bio Structure and Biophysics, Integrated Drug Discovery, Sanofi R&D, Vitry-sur-Seine, France.<br /><searchLink fieldCode="AU" term="%22Green+DJ%22">Green DJ</searchLink>; Transplantation and Cellular Therapy Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Landgren+O%22">Landgren O</searchLink>; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Neri+P%22">Neri P</searchLink>; Department of Oncology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Bergsagel+L%22">Bergsagel L</searchLink>; Department of Medicine, Mayo Clinic, Phoenix, AZ.<br /><searchLink fieldCode="AU" term="%22Braggio+E%22">Braggio E</searchLink>; Department of Medicine, Mayo Clinic, Phoenix, AZ.<br /><searchLink fieldCode="AU" term="%22Kumar+S%22">Kumar S</searchLink>; Department of Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Raab+MS%22">Raab MS</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Medical Faculty, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Fonseca+R%22">Fonseca R</searchLink>; Department of Medicine, Mayo Clinic, Phoenix, AZ.<br /><searchLink fieldCode="AU" term="%22Bahlis+N%22">Bahlis N</searchLink>; Department of Oncology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Weinhold+N%22">Weinhold N</searchLink>; Heidelberg Myeloma Center, Department of Internal Medicine V, Medical Faculty, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Maura+F%22">Maura F</searchLink>; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2025 Sep 25; Vol. 146 (13), pp. 1575-1585. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40493883 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/blood.2024028107 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1575 Titles: – TitleFull: Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Diamond B – PersonEntity: Name: NameFull: Baughn L – PersonEntity: Name: NameFull: Poorebrahim M – PersonEntity: Name: NameFull: Poos AM – PersonEntity: Name: NameFull: Lee H – PersonEntity: Name: NameFull: Kaddoura M – PersonEntity: Name: NameFull: Wiedmeier-Nutor JE – PersonEntity: Name: NameFull: Durante M – PersonEntity: Name: NameFull: Otteson G – PersonEntity: Name: NameFull: Jevremovic D – PersonEntity: Name: NameFull: Tang H – PersonEntity: Name: NameFull: Fröhling S – PersonEntity: Name: NameFull: Baertsch MA – PersonEntity: Name: NameFull: Papadimitriou M – PersonEntity: Name: NameFull: Ziccheddu B – PersonEntity: Name: NameFull: Jelinek T – PersonEntity: Name: NameFull: Lemoine C – PersonEntity: Name: NameFull: Rak A – PersonEntity: Name: NameFull: Green DJ – PersonEntity: Name: NameFull: Landgren O – PersonEntity: Name: NameFull: Neri P – PersonEntity: Name: NameFull: Bergsagel L – PersonEntity: Name: NameFull: Braggio E – PersonEntity: Name: NameFull: Kumar S – PersonEntity: Name: NameFull: Raab MS – PersonEntity: Name: NameFull: Fonseca R – PersonEntity: Name: NameFull: Bahlis N – PersonEntity: Name: NameFull: Weinhold N – PersonEntity: Name: NameFull: Maura F IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 09 Text: 2025 Sep 25 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1528-0020 Numbering: – Type: volume Value: 146 – Type: issue Value: 13 Titles: – TitleFull: Blood Type: main |
| ResultId | 1 |